Document
type: Class

Academic Article
type: Class

Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting
related by: 125994484
type: Generically Dependent Continuant
type: Entity
type: Information Content Entity
type: Continuant
related by: 125994485
most specific type: Academic Article
language: Inglese
related by: 125994477
type: Article
type: Document
type: Academic Article
type: Thing
related by: 125994476

Continuant
type: Class

125994484
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting

Entity
type: Class

Inglese
type: Language

Generically Dependent Continuant
type: Class

individual
rights: termsOfUse
date: 2026-08-27T06:57:33
publisher: Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting
type: Document
label: RDF description of Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting - http://irises.unibs.it/resource/item/175137

Article
type: Class

125994477
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting

125994476
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting

Information Content Entity
type: Class

125994485
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting